01 25Gowling WLG (Canada) LLP
01 12232191
02 12620380
03 32631646
04 32667654
05 32709997
06 32710014
07 32710358
08 32762013
09 32819967
10 22937365
01 16PIRFENIDONE
02 9Pirfenidone
01 9Capsules
02 16TABLET
01 12016-09-17
02 42026-09-22
03 32026-11-29
04 32027-12-18
05 32029-11-09
06 62030-08-17
07 32033-07-04
08 22036-07-28
Patent Expiration Date : 2026-09-22
Date Granted : 2012-10-30
Brand Name : ESBRIET
Patent Number : 2620380
Filing Date : 2006-09-22
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2012-10-30
Patent Expiration Date : 2016-09-17
Date Granted : 2011-03-15
Brand Name : ESBRIET
Patent Number : 2232191
Filing Date : 1996-09-17
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-09-17
Date Granted : 2011-03-15
Patent Expiration Date : 2029-11-09
Date Granted : 2012-03-27
Brand Name : ESBRIET
Patent Number : 2709997
Filing Date : 2009-11-09
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2029-11-09
Date Granted : 2012-03-27
Patent Expiration Date : 2026-09-22
Date Granted : 2014-07-08
Brand Name : ESBRIET
Patent Number : 2762013
Filing Date : 2006-09-22
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-07-08
Patent Expiration Date : 2033-07-04
Date Granted : 2016-03-22
Brand Name : ESBRIET
Patent Number : 2819967
Filing Date : 2013-07-04
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2033-07-04
Date Granted : 2016-03-22
Patent Expiration Date : 2030-08-17
Date Granted : 2016-10-25
Brand Name : ESBRIET
Patent Number : 2710014
Filing Date : 2010-08-17
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-08-17
Date Granted : 2016-10-25
Patent Expiration Date : 2030-08-17
Date Granted : 2016-10-25
Brand Name : ESBRIET
Patent Number : 2710358
Filing Date : 2010-08-17
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-08-17
Date Granted : 2016-10-25
Patent Expiration Date : 2026-11-29
Date Granted : 2016-07-26
Brand Name : ESBRIET
Patent Number : 2631646
Filing Date : 2006-11-29
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-11-29
Date Granted : 2016-07-26
Patent Expiration Date : 2027-12-18
Date Granted : 2016-12-13
Brand Name : ESBRIET
Patent Number : 2667654
Filing Date : 2007-12-18
Strength per Unit : 267 mg
Dosage Form : Capsules
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2027-12-18
Date Granted : 2016-12-13
Patent Expiration Date : 2033-07-04
Date Granted : 2016-03-22
Brand Name : ESBRIET
Patent Number : 2819967
Filing Date : 2013-07-04
Strength per Unit : 267 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-07-04
Date Granted : 2016-03-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
